PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia
CONCLUSIONS: Our streamlined models could be used to assess GTN patients and replace FIGO, statistically matching performance. Given the importance of imaging parameters in guiding treatment, M2 and M3 are favoured for ongoing validation. In resource-poor countries, where access to specialist centres is problematic, M1 could be pragmatically implemented. Further prospective validation on a larger cohort is recommended.PMID:38091775 | DOI:10.1016/j.ygyno.2023.11.017
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Victoria L Parker Matthew C Winter John A Tidy Julia E Palmer Naveed Sarwar Kamaljit Singh Xianne Aguiar Barry W Hancock Allan A Pacey Michael J Seckl Robert F Harrison Source Type: research
More News: Cancer & Oncology | Chemotherapy | Gestational Trophoblastic Tumor | HIV AIDS | OBGYN | Statistics | Study | Training | Universities & Medical Training